Abstract
Infection with Chlamydia pneumoniae occurs worldwide, resulting in a 40-90% prevalence of serum antibody to the species in various populations. Serology is the most commonly used diagnostic tool for the detection of respiratory chlamydial infections in routine clinical practice. The major issue of this study is the validity of the tests used, especially the new rDNA LPS ELISA.
| Translated title of the contribution | Micro-immuno fluorescence for the diagnosis of infectious disease |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 1374-1378 |
| Number of pages | 5 |
| Journal | Acta Microscopica |
| Volume | 28 |
| Issue number | 5 |
| Publication status | Published - 20 Jul 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Diagnosis
- Infectious disease
- Micro-immuno fluorescence
Fingerprint
Dive into the research topics of 'Micro-immuno fluorescence for the diagnosis of infectious disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver